HK1011968A1 - Use of (s)(+)-2-ethoxy-4-(N-(1-(2-piperidinophenyl)-3-methyl-1- butyl)aminocarbonylmethyl)B enzoic acid for the preparation of a longlasting antidiabetic medicament - Google Patents

Use of (s)(+)-2-ethoxy-4-(N-(1-(2-piperidinophenyl)-3-methyl-1- butyl)aminocarbonylmethyl)B enzoic acid for the preparation of a longlasting antidiabetic medicament

Info

Publication number
HK1011968A1
HK1011968A1 HK98112967A HK98112967A HK1011968A1 HK 1011968 A1 HK1011968 A1 HK 1011968A1 HK 98112967 A HK98112967 A HK 98112967A HK 98112967 A HK98112967 A HK 98112967A HK 1011968 A1 HK1011968 A1 HK 1011968A1
Authority
HK
Hong Kong
Prior art keywords
piperidinophenyl
longlasting
aminocarbonylmethyl
ethoxy
butyl
Prior art date
Application number
HK98112967A
Inventor
Michael Mark
Wolfgang Grell
Andreas Greischel
Gabriele Zahn
Hansjorg Knorr
Eckhard Rupprecht
Ulrich Muller
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36781542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1011968(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of HK1011968A1 publication Critical patent/HK1011968A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK98112967A 1991-06-21 1998-12-08 Use of (s)(+)-2-ethoxy-4-(N-(1-(2-piperidinophenyl)-3-methyl-1- butyl)aminocarbonylmethyl)B enzoic acid for the preparation of a longlasting antidiabetic medicament HK1011968A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/EP1991/001147 WO1993000337A1 (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
SG1996002715A SG43036A1 (en) 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid
CA002111851A CA2111851C (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
CN91104984A CN1048722C (en) 1991-06-21 1991-07-22 (S)(+)-2-Ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof

Publications (1)

Publication Number Publication Date
HK1011968A1 true HK1011968A1 (en) 1999-07-23

Family

ID=36781542

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98112967A HK1011968A1 (en) 1991-06-21 1998-12-08 Use of (s)(+)-2-ethoxy-4-(N-(1-(2-piperidinophenyl)-3-methyl-1- butyl)aminocarbonylmethyl)B enzoic acid for the preparation of a longlasting antidiabetic medicament

Country Status (19)

Country Link
EP (1) EP0589874B1 (en)
JP (1) JP2921982B2 (en)
KR (1) KR100496720B1 (en)
CN (1) CN1048722C (en)
AU (1) AU660930B2 (en)
BG (1) BG61690B1 (en)
CA (1) CA2111851C (en)
DE (2) DE10075006I2 (en)
DK (2) DK0965591T3 (en)
FI (1) FI106027B (en)
GR (1) GR3031654T3 (en)
HK (1) HK1011968A1 (en)
NO (2) NO303687B1 (en)
PL (1) PL170210B1 (en)
RO (1) RO113462B1 (en)
SG (1) SG43036A1 (en)
SK (1) SK281246B6 (en)
UY (1) UY25923A1 (en)
WO (1) WO1993000337A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1011673E (en) 1997-06-13 2001-11-30 Novo Nordisk As NEW DOSAGE FOR THE NDMD
IN192862B (en) 1999-11-16 2004-05-22 Ranbaxy Lab Ltd
AR033390A1 (en) 2000-08-22 2003-12-17 Novartis Ag A PHARMACEUTICAL COMPOSITION THAT INCLUDES AN ATTA RECEIVER ANTAGONIST AND A POTENTIATOR OF THE INSULIN SECRETION, THE USE OF SUCH COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND A PARTS KIT
CN1649614A (en) 2002-02-22 2005-08-03 新河药品股份有限公司 Active agent delivery systems and methods for protecting and administering active agents
WO2004018442A1 (en) * 2002-08-23 2004-03-04 Dr. Reddy's Laboratories Limited Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof
US7915421B2 (en) * 2003-05-14 2011-03-29 Cilag Ltd. Method for preparing phenyl acetic acid derivatives
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005021524A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of repaglinide
CN1305863C (en) * 2004-12-27 2007-03-21 浙江大学 Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine
GT200600381A (en) 2005-08-25 2007-03-28 ORGANIC COMPOUNDS
FR2898894B1 (en) * 2006-03-24 2008-06-06 Genfit Sa SUBSTITUTED N- (PHENETHYL) BENZAMIDE DERIVATIVE COMPOUNDS, PREPARATION AND USES
US7763607B2 (en) * 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
CA2666846C (en) * 2006-10-20 2018-04-10 Cpd, Llc Method of restoring the incretin effect
US8101769B2 (en) 2007-02-15 2012-01-24 Actavis Group Ptc Ehf Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide
CN101772491A (en) * 2007-06-06 2010-07-07 阿克塔维什集团Ptc公司 Repaglinide substantially free of dimer impurity
EP2019097A1 (en) 2007-07-25 2009-01-28 Aurobindo Pharma Limited Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine
DK2200588T3 (en) 2007-09-25 2019-07-01 Solubest Ltd COMPOSITIONS CONCERNING LIPOFILE ACTIVE RELATIONS AND METHOD OF PRODUCTION THEREOF
DE102008046995B4 (en) * 2008-09-12 2010-08-26 Stada Arzneimittel Ag 2-ethoxy-benzoic acid
EP2177221A1 (en) 2008-10-20 2010-04-21 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of substantially optically pure Repaglinide and precursors thereof
BRPI1010600A2 (en) 2009-05-15 2016-03-15 Novartis Ag aryl pyridine as aldosterone synthase inhibitors
CN102459247B (en) 2009-05-15 2014-09-17 诺华股份有限公司 Benzoxazolone derivatives as aldosterone symthase inhibitors
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
KR101442897B1 (en) 2009-05-28 2014-09-23 노파르티스 아게 Substituted aminopropionic derivatives as neprilysin inhibitors
US8519134B2 (en) 2009-11-17 2013-08-27 Novartis Ag Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
WO2011064376A1 (en) 2009-11-30 2011-06-03 Novartis Ag Imidazole derivatives as aldosterone synthase inhibitors
EP2364977A1 (en) 2010-01-26 2011-09-14 Reuter Chemische Apparatebau KG Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
CN102267959B (en) * 2011-07-06 2013-05-01 海南锦瑞制药股份有限公司 Repaglinide crystal, preparation method thereof, and solid oral preparation containing same
CN103012319B (en) * 2011-09-20 2015-06-10 浙江九洲药业股份有限公司 Repaglinide intermediate synthesis process improvement
CN102584743A (en) * 2011-12-28 2012-07-18 中国药科大学 Dimethylaminopyridine repaglinide eutectic
UY35144A (en) 2012-11-20 2014-06-30 Novartis Ag APELINE SYNTHETIC LINEAR MIMETICS FOR THE CARDIAC INSUFFICIENCY TREATMENT
NZ710574A (en) 2013-02-14 2017-11-24 Novartis Ag Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors
US9340582B2 (en) 2013-07-25 2016-05-17 Novartis Ag Bioconjugates of synthetic apelin polypeptides
WO2015013168A1 (en) 2013-07-25 2015-01-29 Novartis Ag Cyclic polypeptides for the treatment of heart failure
WO2016073615A1 (en) 2014-11-07 2016-05-12 Regents Of The University Of Minnesota Salts and compositions useful for treating disease
CA2972871A1 (en) 2015-01-23 2016-07-28 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
WO2018034627A1 (en) 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
UY38072A (en) 2018-02-07 2019-10-01 Novartis Ag COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347565A1 (en) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
CA2111851A1 (en) 1993-01-07
SK128093A3 (en) 1994-11-09
SK281246B6 (en) 2001-01-18
NO934726L (en) 1993-12-20
AU660930B2 (en) 1995-07-13
GR3031654T3 (en) 2000-02-29
FI935724A0 (en) 1993-12-20
NO1999017I1 (en) 1999-07-20
DK0589874T3 (en) 2000-04-03
JPH06508816A (en) 1994-10-06
EP0589874B1 (en) 1999-09-08
AU8078191A (en) 1993-01-25
WO1993000337A1 (en) 1993-01-07
DE10075006I2 (en) 2004-01-08
JP2921982B2 (en) 1999-07-19
BG98300A (en) 1994-09-30
DE10075006I1 (en) 2000-04-20
CA2111851C (en) 2002-02-26
DE59109151D1 (en) 1999-10-14
NO303687B1 (en) 1998-08-17
CN1068820A (en) 1993-02-10
PL170210B1 (en) 1996-11-29
KR100496720B1 (en) 2006-01-27
FI106027B (en) 2000-11-15
FI935724A (en) 1993-12-20
NO934726D0 (en) 1993-12-20
SG43036A1 (en) 1997-10-17
BG61690B1 (en) 1998-03-31
DK0965591T3 (en) 2002-11-18
EP0589874A1 (en) 1994-04-06
RO113462B1 (en) 1998-07-30
UY25923A1 (en) 2001-08-27
CN1048722C (en) 2000-01-26

Similar Documents

Publication Publication Date Title
HK1011968A1 (en) Use of (s)(+)-2-ethoxy-4-(N-(1-(2-piperidinophenyl)-3-methyl-1- butyl)aminocarbonylmethyl)B enzoic acid for the preparation of a longlasting antidiabetic medicament
PT84737A (en) N-(2(-aminophenyl)-benzamide derivatives process for the preparation thereof and pharmaceutical compositions containing them
CS930586A2 (en) Zpusob vyroby monohydratu n,n dimethyl 1 ( 1 ( 4 chlorfenyl ) cyklobutyl ) 3 methylbutylamin hydrochloridu
PH25048A (en) N-substituted benzamides
IL75038A0 (en) 2-(n-substituted guanidino)-4-heteroarylthiazoles and pharmaceutical compositions containing them
IT1223654B (en) DEVICE FOR THE APPLICATION TO THE CUT END OF A SHEET FOR VENEERING
ZA873933B (en) N-(5-substituted methylene-phenyl)herbicides
ZA882449B (en) Dihydropyridinamides,a process for their preparation,and their use in medicaments
AU8225391A (en) The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist
DE3664036D1 (en) (1-phenylmethyl-5-hydroxy-1h-indazol-3-yl)-oxyacetic acid and salts thereof for use as a medicament, and pharmaceutical compositions containing them
IL86173A (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU2958789A (en) Amino acid amides with a psychotropic action, processes for their preparation, agents containing them and their use
AU589921B2 (en) N-(2-dialkylaminoethyl) benzamides process for their manufacture and their pharmaceutical use
DE3169052D1 (en) N-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methyl-sulfamoyl benzamide, process for its preparation and its use as a medicine
NZ219719A (en) Endo-4-amino-5-chloro-2-methoxy-n-cl-azabicyclo -(3,3,1)-non-4-yl)-benzamide and pharmaceutical compositions
ZA82639B (en) 4-(1-imidazolylmetyl)cinnamic acid hydrochloride monohydrate and pharmaceutical compositions containing the same
EP0338424A3 (en) N-((6-trifluoromethylpyrimidin-2-yl)-aminocarbonyl)-2-carboalkoxy-benzenesulfonamides, process for their preparation and their use
IL64755A (en) 1-(2-(4,5,10,11-tetrahydro-1h-dibenzo(a,d)cyclohepten-5-yl)-ethyl)pyrrolidine and pharmaceutically acceptable acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL84787A (en) Herbicidal composition containing n-(3-alkynyloxy-chloro-5-fluoro)tetrahydrophthalimide and a phenoxyalkanoic acid derivative
EP0298465A3 (en) Antidiabetic agent
ZA934667B (en) N-derivatives of (phenylethyl-Béta-ol) amine, a process for their preparation and pharmaceutical compositions containing the same
GB2177087B (en) Analgetic and antiemetic 3-(substituted-phenyl)cyclohexanol derivatives
IL84343A0 (en) Pharmaceutical compositions containing a dithiaazaspinanonane derivative for use against hypertension and congestive heart failure
HRP940769B1 (en) (s)(+)-2-ethoxy-4-(n-(1-(2-piperidinophenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)benzoic acid, medicines containing them, that compound and processes for the preparation thereof
IL87678A0 (en) N-(substituted alkylidene)fused-bicycloalkylidene or heteroalkylidene quinolinamines,a process for their preparation and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
PF Patent in force
CHPA Change of a particular in the register (except of change of ownership)
PE Patent expired

Effective date: 20110620